This federal drug discount program is actually boosting cancer care costs
(By Debra Patt for STAT) Given its name, you’d expect the federal 340B Drug Discount Program1 to save money for
Read More(By Debra Patt for STAT) Given its name, you’d expect the federal 340B Drug Discount Program1 to save money for
Read More(By Ed Silverman for STAT) Someone at Nippon Fine Chemical must have been very nervous when an investigator from the
Read More(By Rhitu Chatterjee for NPR) Diet and nutrition are now the biggest risk factors for people’s health across the globe,
Read More(By Virginia Anderson for NPR) Shela Bryan, 63, has been comparing prices for individual health insurance plans since May, and
Read More(By Melissa Quinn for The Daily Signal) Republican Rep. Chris Stewart of Utah has mounted a campaign urging House Speaker
Read More(By Ed Silverman for STAT) At a time when drug makers are under intense scrutiny for their pricing, Ariad Pharmaceuticals
Read More(‘By Ed Silverman for STAT) Mylan reached a $465 million settlement on Friday with the US Department of Justice and
Read More(By Meghana Keshavan for STAT) The race to create the next potent ovarian cancer drug is coming to a head. Ovarian
Read MoreThe outsourcing of Chronic Care Management to external technology-based firms is explored in an article posted www.healthcare-informatics.com by David Raths. Recapping the
Read More(By Emily Kopp for Kaiser Health News) As Zika skipped into Puerto Rico and then Florida this summer and threatened
Read More